Niagen Bioscience (NAGE)
NASDAQ:NAGE
Want to see NAGE full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.02Last Year’s EPS
0.04Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone: solid revenue and net income, strong e-commerce growth, margin stability, a robust cash position, and several strategic wins (USP monograph, new product launches, scientific leadership). Offsetting items include short-term cash flow drag from inventory and timing, higher selling/marketing and G&A investments, channel volatility with some distribution partners, and intensified competition and regulatory uncertainty around NMN which is creating headwinds. Management reaffirmed full-year guidance (10%–15% growth) while electing to invest in marketing and product rollouts to drive future growth.Company Guidance
Revenue and Profitability
Total revenue of $31.5M ($31.1M excluding divested reference standards), representing a 5% year-over-year increase. Net income of $6.3M and diluted EPS of $0.08 vs $0.07 year-ago.
Strong E‑commerce Growth
Core e-commerce grew 14% year-over-year; TRU NIAGEN e-commerce sales were $19.2M (up $2.4M). Direct-to-consumer website grew about twice as fast as Amazon.
Ingredient Sales and Mix
NIAGEN ingredient revenue of $8.2M (up 2% or $0.185M YoY), including $7.3M food-grade and $0.85M pharma-grade sales, supporting broadened B2B demand.
Healthy Gross Margin and Strong Balance Sheet
Gross margin improved slightly to 63.5% (up 10 basis points vs prior year). Ended quarter with $66.5M cash, no debt, and working capital of $82.3M (working capital increased ~$5.4M from prior quarter).
Product Launch Successes — Niagen Plus and NanoCloud
Launched Niagen Plus at‑home injection kit + telehealth capability with strong initial traffic/conversions and positive early feedback. Pilot-launched Niagen NanoCloud skincare, reporting strong early demand (nearly sold out) and favorable consumer survey results; wide roll-out planned for October.
Regulatory & Quality Differentiation — USP Monograph
NIAGEN (NR chloride) achieved a published USP dietary supplement ingredient monograph — a rare benchmark for supplements and a notable quality differentiation versus competitors.
Clinical & Scientific Leadership
Sponsored the NAD for Health scientific meeting; highlighted emerging research (tissue NAD importance, potential benefits of IV/injection for tissue NAD, synergy with exercise). Progressing toward IND-enabling preclinical work for orphan indications (e.g., ataxia telangiectasia).
Commercial Footprint Expansion
NIAGEN available in ~1,200 clinics for IV offerings with strong order and repeat rates; discussions underway with two major skincare brands and broader distribution plans (international and selective retail).
NAGE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NAGE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $4.97 | $4.19 | -15.69% |
Mar 04, 2026 | $4.94 | $5.10 | +3.24% |
Nov 04, 2025 | $6.95 | $6.88 | -1.01% |
Aug 06, 2025 | $9.40 | $9.61 | +2.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Niagen Bioscience (NAGE) report earnings?
Niagen Bioscience (NAGE) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is Niagen Bioscience (NAGE) earnings time?
Niagen Bioscience (NAGE) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NAGE EPS forecast?
NAGE EPS forecast for the fiscal quarter 2026 (Q2) is 0.02.